1. Voordrachten en abstracts van de The sixt Conference of the International Coenzyme Q10 Association. Mei 2010
2. Littarru GP. Energy and Defense. Facts and perspectives on Coenzyme Q10 in biology and medecine. ISBN 88-86062-24-9
3. Dhanasekaran M, et al. The emerging role of CoQ10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes. Curr Neurovasc Res. 2005 Dec;2(5):447-59.
4. Hodgson JM, Watts GF, Playford DA, Burke V, Croft KD. Coenzyme Q10 improves blood pressure and glycaemic control in a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr. 2002 Nov;56(11):1137-42.
5. Littarru GP, Tiano L. Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Mol Biotechnol. 2007 Sep;37(1):31-7.
6. Cuttler RG. Antioxidants and aging. Am J Clin Nutr 1991; 53:373-9S.
7. Dhanasekaran M, Ren J. The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitus. Curr Neurovasc Res 2005 Dec;2(5):447-59.
8. Hasegawa G et al. Daily profile of plasma %CoQ10 level, a biomarker of oxidative stress, in patients with diabetes manifesting postprandial hyperglycaemia. Acta Diabetol. 2005 Dec;42(4):179-81.
9. Rolo AP, Palmeira CM. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol. 2006 Apr 15;212(2):167-78.
10. Menke T et al. Pediatr Diabetes. Antioxidant level and redox status of coenzyme Q10 in the plasma and blood cells of children with diabetes mellitus type 1. 2008 Dec;9(6):540-5.
11. Sivitz WI, Yorek MA. Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal. 2010 Apr;12(4):537-77.
12. Heuer T, Gerards H, Pauw M, Gabbert HE, Reis HE. Toxic liver damage caused by HMG-CoA reductase inhibitor. Med Klin (Munich). 2000 Nov 15;95(11):642-4.
13. Hartleb M, Rymarczyk G, Januszewski K. Acute cholestatic hepatitis associated with pravastatin. Am J Gastroenterol. 1999 May;94(5):1388-90.
14. Koornstra JJ, Ottervanger JP, Fehmers MC, Stricker BH. Clinically manifest liver lesions during use of simvastatin. Ned Tijdschr Geneeskd. 1996 Apr 13;140(15):846-8.
15. Ballarè M et al. Hepatotoxicity of hydroxy-methyl-glutaryl-coenzyme A reductase inhibitors. Minerva Gastroenterol Dietol. 1992 Jan-Mar;38(1):41-4.
16. Becker C, Hvalic C, Delmore G, Krähenbühl S, Schlienger R. Recurrent acute pancreatitis during pravastatin-therapy. Praxis (Bern 1994). 2006 Jan 25;95(4):111-6.
17. Singh S, Nautiyal A, Dolan JG. Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect? JOP. 2004 Nov 10;5(6):502-4.
18. Tsigrelis C, Pitchumoni CS. Pravastatin: a potential cause for acute pancreatitis. World J Gastroenterol. 2006 Nov 21;12(43):7055-7.
19. Tysk C, Al-Eryani AY, Shawabkeh AA. Acute pancreatitis induced by fluvastatin therapy. J Clin Gastroenterol. 2002 Nov-Dec;35(5):406-8.
20. Anagnostopoulos GK et al. Acute pancreatitis due to pravastatin therapy. JOP. 2003 May;4(3):129-32.
21. Agarwal A, Gupta S, Sekhon L, Shah R. Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications. Antioxid Redox Signal. 2008 Aug;10(8):1375-403.
22. Al-Gubory KH, Fowler PA, Garrel C. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int J Biochem Cell Biol. 2010 Oct;42(10):1634-50. Epub 2010 Jun 19.
23. Roland L, Gagné A, Bélanger MC, Boutet M, Berthiaume L, Fraser WD, Julien P, Bilodeau JF. Existence of compensatory defense mechanisms against oxidative stress and hypertension in preeclampsia. Hypertens Pregnancy. 2010 Jan;29(1):21-37.
24. Teran E, Hernandez I, Nieto B, Tavara R, Ocampo JE, Calle A. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia. Int J Gynaecol Obstet. 2009 Apr;105(1):43-5.
25. Coenzyme Q10 treatment in infertile men with idiopathic asthenozoospermia: a placebo-controlled, double-blind randomized trial. Fertil Steril. 2009 May;91(5):1785-92.
26. Agarwal A, Sekhon LH. The role of antioxidant therapy in the treatment of male infertility. Hum Fertil (Camb). 2010 Dec;13(4):217-25.
27. Sheweita SA, Tilmisany AM, Al-Sawaf H. Mechanisms of male infertility: role of antioxidants. Curr Drug Metab. 2005 Oct;6(5):495-501.
28. Balercia G, Littaru GP et al. Coenzyme Q10 and male infertility.J Endocrinol Invest. 2009 Jul;32(7):626-32.
29. Mancini A et al. Hormones and antioxidant systems: role of pituitary and pituitary-dependent axes. J Endocrinol Invest. 2010 Jun;33(6):422-33.
30. Mancini A et al. Evaluation of antioxidant systems in pituitary-adrenal axis diseases. Pituitary. 2010 Jun;13(2):138-45.
31. Bianchi G et al. Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment. Horm Metab Res. 1999 Nov;31(11):620-4.
32. Mano T et al. Vitamin E and coenzyme Q concentrations in the thyroid tissues of patients with various thyroid disorders. Am J Med Sci. 1998 Apr;315(4):230-2.
33. Blatt T et al. Stimulation of skin's energy metabolism provides multiple benefits for mature human skin. Biofactors. 2005;25(1-4):179-85.
34. Hoppe U et al. Coenzyme Q10, a cutaneous antioxidant and energizer. Biofactors. 1999;9(2-4):371-8.
35. Blasi MA, Bovina C, Carella G, et al. Does coenzyme Q10 play a role in opposing oxidative stress in patients with age-related macular degeneration? Opthalmologica. 2001 Jan-Feb;215(1):51-
36. Salami A, Mora R, Dellepiane M, et al. Water-soluble coenzyme Q10 formulation (Q-TER(®)) in the treatment of presbycusis. Acta Otolaryngol. 2010 Oct;130(10):1154-62.